PROCEPT BioRobotics CorpPRCTEarnings & Financial Report
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Revenue
$79.2M
Gross Profit
$51.7M
Operating Profit
$-22.2M
Net Profit
$-19.6M
Gross Margin
65.4%
Operating Margin
-28.0%
Net Margin
-24.7%
YoY Growth
48.4%
EPS
$-0.35
PROCEPT BioRobotics Corp Q2 FY2025 Financial Summary
PROCEPT BioRobotics Corp reported revenue of $79.2M (up 48.4% YoY) for Q2 FY2025, with a net profit of $-19.6M (up 23.6% YoY) (-24.7% margin). Cost of goods sold was $27.4M, operating expenses totaled $73.9M.
Key Financial Metrics
| Total Revenue | $79.2M |
|---|---|
| Net Profit | $-19.6M |
| Gross Margin | 65.4% |
| Operating Margin | -28.0% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
PROCEPT BioRobotics Corp Q2 FY2025 revenue of $79.2M breaks down across 4 segments, led by Hand Pieces And Other Consumables at $43.1M (54.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Hand Pieces And Other Consumables | $43.1M | 54.5% |
| System Sales And Rentals | $22.1M | 27.9% |
| Outside The United States | $9.6M | 12.1% |
| Service Revenue | $4.4M | 5.5% |
PROCEPT BioRobotics Corp Revenue by Segment — Quarterly Trend
PROCEPT BioRobotics Corp revenue by segment across the last 4 reported quarters, showing how each business line (such as Hand Pieces And Other Consumables and System Sales And Rentals) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Hand Pieces And Other Consumables | $34.1M | $44.4M | $43.1M | $38.0M |
| System Sales And Rentals | $27.5M | $24.7M | $22.1M | $18.7M |
| Outside The United States | — | $9.4M | $9.6M | $8.9M |
| Service Revenue | $5.0M | $4.8M | $4.4M | $3.6M |
PROCEPT BioRobotics Corp Annual Revenue by Year
PROCEPT BioRobotics Corp annual revenue history includes year-by-year totals (for example, 2025 revenue was $308.1M).
| Year | Annual Revenue |
|---|---|
| 2025 | $308.1M |
| 2024 | $224.5M |
| 2023 | $136.2M |
| 2022 | $75.0M |
PROCEPT BioRobotics Corp Quarterly Revenue & Net Profit History
PROCEPT BioRobotics Corp results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $76.4M | +11.9% | $-29.8M | -39.1% |
| Q3 FY2025 | $83.3M | +42.8% | $-21.4M | -25.7% |
| Q2 FY2025 | $79.2M | +48.4% | $-19.6M | -24.7% |
| Q1 FY2025 | $69.2M | +55.3% | $-24.7M | -35.8% |
| Q4 FY2024 | $68.2M | +56.6% | $-18.9M | -27.6% |
| Q3 FY2024 | $58.4M | +66.3% | $-21.0M | -35.9% |
| Q2 FY2024 | $53.4M | +61.2% | $-25.6M | -48.0% |
| Q1 FY2024 | $44.5M | +82.5% | $-26.0M | -58.3% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44.5M | $53.4M | $58.4M | $68.2M | $69.2M | $79.2M | $83.3M | $76.4M |
| YoY Growth | 82.5% | 61.2% | 66.3% | 56.6% | 55.3% | 48.4% | 42.8% | 11.9% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $382.9M | $374.4M | $374.1M | $534.0M | $519.4M | $513.1M | $511.5M | $508.1M |
| Liabilities | $118.9M | $122.6M | $132.9M | $131.8M | $130.2M | $127.3M | $131.3M | $142.2M |
| Equity | $264.0M | $251.8M | $241.2M | $402.2M | $389.2M | $385.8M | $380.3M | $365.9M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-32.3M | $-15.7M | $-18.8M | $-32.4M | $-17.0M | $-15.0M | $-6.6M | $-10.3M |